Down-regulation of ribosomal protein S15A mRNA with a short hairpin RNA inhibits human hepatic cancer cell growth in vitro

Gene

Volumn 536, Issue 1, 2014, Pages 84-89

  Xu, Maiyu ^a   Wang, Yi ^b   Chen, Lei ^a   Pan, Bujian ^a   Chen, Feng ^a   Fang, Yang ^a   Yu, Zhengping ^b   Chen, Gang ^b  

^a WENZHOU CENTRAL HOSPITAL   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Growth; Hepatocellular carcinoma; RPS15A; ShRPS15A

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; LENTIVIRUS VECTOR; MESSENGER RNA; RIBOSOMAL PROTEIN S15A; RIBOSOME PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN HEPG2; COLONY FORMATION; COLONY FORMING UNIT; CONTROLLED STUDY; DOWN REGULATION; FLUORESCENCE ACTIVATED CELL SORTING; G1 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; LENTIVIRINAE; LIVER CANCER; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM;

LENTIVIRUS;

EID: 84891831232     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.11.075     Document Type: Article

References (25)

1. Akiyama N., Matsuo Y., Sai H., Noda M., Kizaka-Kondoh S. Identification of a series of transforming growth factor beta-responsive genes by retrovirus-mediated gene trap screening. Mol. Cell. Biol. 2000, 20:3266-3273.
2. Bonham-Smith P.C., Moloney M.M. Nucleotide and protein sequences of a cytoplasmic ribosomal protein S15a gene from Arabidopsis thaliana. Plant Physiol. 1994, 106:401-402.
3. Bonham-Smith P.C., Oancia T.L., Moloney M.M. Cytoplasmic ribosomal protein S15a from Brassica napus: molecular cloning and developmental expression in mitotically active tissues. Plant Mol. Biol. 1992, 18:909-919.
4. Bosetti C., Levi F., Boffetta P., Lucchini F., Negri E., La Vecchia C. Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology 2008, 48:137-145.
5. El-Serag H.B., Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 1999, 340:745-750.
6. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576.
7. Ioannou G.N., Bryson C.L., Weiss N.S., Miller R., Scott J.D., Boyko E.J. The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection. Hepatology 2013, 57:249-257.
8. Jemal A., et al. Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58:71-96.
9. Lavoie C., Tam R., Clark M., Lee H., Sonenberg N., Lasko P. Suppression of a temperature-sensitive cdc33 mutation of yeast by a multicopy plasmid expressing a Drosophila ribosomal protein. J. Biol. Chem. 1994, 269:14625-14630.
10. Lee D.K., et al. The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev. 2001, 15:455-466.
11. Li Y., Chen L., Chan T.H., Guan X.Y. Hepatocellular carcinoma: transcriptome diversity regulated by RNA editing. Int. J. Biochem. Cell Biol. 2013, 45:1843-1848.
12. Lian Z., et al. Human S15a expression is upregulated by hepatitis B virus×protein. Mol. Carcinog. 2004, 40:34-46.
13. Liu A.W., et al. ShRNA-targeted MAP4K4 inhibits hepatocellular carcinoma growth. Clin. Cancer Res. 2011, 17:710-720.
14. Mancuso A., et al. Hepatocellular carcinoma on cirrhosis-free liver in a HCV-infected thalassemic. Am. J. Hematol. 2005, 78:158-159.
15. Merchante N., et al. Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain. Clin. Infect. Dis. 2013, 56:143-150.
16. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55:74-108.
17. Puck T.T., Marcus P.I. Action of X-rays on mammalian cells. J. Exp. Med. 1956, 103:653-666.
18. Reed S.I. The selection of S. cerevisiae mutants defective in the start event of cell division. Genetics 1980, 95:561-577.
19. Sahasrabuddhe V.V., Shiels M.S., McGlynn K.A., Engels E.A. The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States. Cancer 2012, 118:6226-6233.
20. Sakoda T., Kasahara N., Hamamori Y., Kedes L. A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes. J. Mol. Cell. Cardiol. 1999, 31:2037-2047.
21. Soneoka Y., et al. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 1995, 23:628-633.
22. Tiscornia G., Singer O., Verma I.M. Production and purification of lentiviral vectors. Nat. Protoc. 2006, 1:241-245.
23. Tricoli J.V., Bracken R.B. ZFY gene expression and retention in human prostate adenocarcinoma. Gene Chromosome. Cancer 1993, 6:65-72.
24. Zheng L., et al. ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth. PLoS One 2012, 7:e45412.
25. Zhou J., et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J. Clin. Oncol. 2011, 29:4781-4788.